Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
aelf will distribute 120 million ELF tokens as rewards to BPs, candidate nodes, and voters, accounting for 12% of its total supply

aelf will distribute 120 million ELF tokens as rewards to BPs, candidate nodes, and voters, accounting for 12% of its total supply

2024/01/19 07:47

The public chain project aelf announced that in order to encourage governance participation, aelf will reserve 120 million ELF tokens (equivalent to 12% of the total supply of ELF) as rewards for BPs, candidate nodes, and voters. BPs can also receive additional rewards, including transaction fees, SideChain index fees, and resource token transaction fees. In the governance election, there is no limit on the number of voters, but there are limitations on the number of BPs and candidate nodes. The total upper limit for BPs is 2N+1. It is reported that aelf adopts the AEDPoS consensus mechanism and distributes governance authority to three important roles that jointly maintain aelf: block producers (BPs), candidate nodes, and voters. BPs are full nodes that store data, verify transactions, and participate in aelf governance by voting on proposals for parliament. Candidate nodes have the potential to become BPs and need to participate in governance elections. Voters are holders of Mainnet ELF tokens who vote for nodes by staking ELF tokens.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment

According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.

智通财经•2026/11/06 08:27

GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions

Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.

智通财经•2026/11/06 07:56